Additionally, another study suggested that oral gavage with 50 mg/kg FA for 8 weeks improved DCM via activating cardiac PI3K, Akt and glycogen synthase kinase 3β (GSK-3β), and ameliorating the translocation of glucose transporter type 4 (GLUT4) to the cardiac membrane by activating PI3K/Akt signaling pathway in STZ-induced Wistar rats [89]. The gene discussed is AKT1; the disease is familial dilated cardiomyopathy.